Volume 4, Issue 3, Pages (March 2015)

Slides:



Advertisements
Similar presentations
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Advertisements

Volume 14, Issue 4, Pages (February 2016)
Volume 3, Issue 6, Pages (December 2014)
Volume 8, Issue 3, Pages (March 2017)
Hypoxia reduces the inhibitory effect of IL-1β on chondrogenic differentiation of FCS- free expanded MSC  T. Felka, R. Schäfer, B. Schewe, K. Benz, W.K.
Volume 3, Issue 1, Pages 5-14 (July 2014)
Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC- derived chondrocytes  R.S. Rainbow, H. Kwon, A.T. Foote, R.C. Preda, D.L.
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling  T.-L. Tsai, P.A. Manner,
Stepwise preconditioning enhances mesenchymal stem cell-based cartilage regeneration through epigenetic modification  S. Lin, W.Y.W. Lee, L. Xu, Y. Wang,
Volume 7, Issue 2, Pages (August 2016)
Hypoxia reduces the inhibitory effect of IL-1β on chondrogenic differentiation of FCS- free expanded MSC  T. Felka, R. Schäfer, B. Schewe, K. Benz, W.K.
Identification of Bone Marrow-Derived Soluble Factors Regulating Human Mesenchymal Stem Cells for Bone Regeneration  Tsung-Lin Tsai, Wan-Ju Li  Stem Cell.
Volume 11, Issue 2, Pages (August 2018)
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Restoration of Corneal Transparency by Mesenchymal Stem Cells
TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes  R. Narcisi, L. Signorile,
Volume 9, Issue 2, Pages (August 2017)
Identification of small molecular compounds and fabrication of its aqueous solution by laser-ablation, expanding primordial cartilage  D. Ikegami, T.
Subtractive gene expression profiling of articular cartilage and mesenchymal stem cells: serpins as cartilage-relevant differentiation markers  S. Boeuf,
Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state  N. Fahy, M.L. de Vries-van.
Volume 5, Issue 6, Pages (December 2015)
Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation  D. Correa, R.A. Somoza, P. Lin, S. Greenberg,
C.B. Chang, S.A. Han, E.M. Kim, S. Lee, S.C. Seong, M.C. Lee 
Volume 4, Issue 3, Pages (March 2015)
HIF-1α as a Regulator of BMP2-Induced Chondrogenic Differentiation, Osteogenic Differentiation, and Endochondral Ossification in Stem Cells Cell Physiol.
Volume 6, Issue 4, Pages (April 2016)
C.B. Chang, S.A. Han, E.M. Kim, S. Lee, S.C. Seong, M.C. Lee 
Volume 20, Issue 12, Pages (September 2017)
Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture  Dr R.L. Mauck, Ph.D., X. Yuan, Dr.
Isolation of multipotent mesenchymal stem cells from umbilical cord blood by Oscar K. Lee, Tom K. Kuo, Wei-Ming Chen, Kuan-Der Lee, Shie-Liang Hsieh, and.
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Makoto Takeo, Christopher S. Hale, Mayumi Ito 
H.H. Lee, M.J. O'Malley, N.A. Friel, C.R. Chu 
Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation  D.C. Lacey, P.J. Simmons,
Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets
T. Kimura, T. Ozaki, K. Fujita, A. Yamashita, M. Morioka, K. Ozono, N
Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human 
Single cell sorting identifies progenitor cell population from full thickness bovine articular cartilage  Y. Yu, H. Zheng, J.A. Buckwalter, J.A. Martin 
A predominantly articular cartilage-associated gene, SCRG1, is induced by glucocorticoid and stimulates chondrogenesis in vitro  Kensuke Ochi, M.D., Ph.D.,
Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins  M. Pei, M.D., Ph.D., J. Luo, M.D.,
M. A. Cleary, R. Narcisi, K. Focke, R. van der Linden, P. A. J
Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications 
Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor  H. Tanoue, J. Morinaga, T. Yoshizawa,
Spatial regulation of human mesenchymal stem cell differentiation in engineered osteochondral constructs: effects of pre-differentiation, soluble factors.
Volume 4, Issue 1, Pages (January 2015)
Derivation and FACS-Mediated Purification of PAX3+/PAX7+ Skeletal Muscle Precursors from Human Pluripotent Stem Cells  Bianca Borchin, Joseph Chen, Tiziano.
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Magnesium enhances adherence and cartilage formation of synovial mesenchymal stem cells through integrins  M. Shimaya, T. Muneta, S. Ichinose, K. Tsuji,
Volume 1, Issue 6, Pages (December 2013)
Cell surface receptor expression profile of human synovial mesenchymal stem cells in- vivo predicts their differentiation potential in-vitro  N.U. Aljezani,
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
Volume 3, Issue 6, Pages (December 2014)
Volume 4, Issue 3, Pages (March 2015)
Volume 3, Issue 6, Pages (December 2014)
Identification of White Adipocyte Progenitor Cells In Vivo
Katherine C. Krueger, Maria José Costa, Hongqing Du, Brian J. Feldman 
Membrane culture and reduced oxygen tension enhances cartilage matrix formation from equine cord blood mesenchymal stromal cells in vitro  C. Co, M.K.
Kim L. Kroeze, Wouter J. Jurgens, Behrouz Z. Doulabi, Florine J
Volume 3, Issue 3, Pages (September 2014)
Volume 11, Issue 5, Pages (November 2018)
In Vivo Human Somitogenesis Guides Somite Development from hPSCs
Volume 2, Issue 3, Pages (March 2014)
Volume 9, Issue 1, Pages (July 2017)
Volume 10, Issue 3, Pages (March 2018)
Volume 1, Issue 1, Pages (June 2013)
Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage  S. Clockaerts,
Volume 14, Issue 4, Pages (February 2016)
Volume 8, Issue 6, Pages (June 2017)
Effect of expansion medium on ex vivo gene transfer and chondrogenesis in type II collagen–glycosaminoglycan scaffolds in vitro  R.M. Capito, Ph.D., M.
Volume 9, Issue 1, Pages (July 2017)
Presentation transcript:

Volume 4, Issue 3, Pages 459-472 (March 2015) Long-Term Expansion, Enhanced Chondrogenic Potential, and Suppression of Endochondral Ossification of Adult Human MSCs via WNT Signaling Modulation  Roberto Narcisi, Mairéad A. Cleary, Pieter A.J. Brama, Martin J. Hoogduijn, Nesrin Tüysüz, Derk ten Berge, Gerjo J.V.M. van Osch  Stem Cell Reports  Volume 4, Issue 3, Pages 459-472 (March 2015) DOI: 10.1016/j.stemcr.2015.01.017 Copyright © 2015 The Authors Terms and Conditions

Figure 1 WNT3A in Combination with FGF2 Enhances Expansion and Chondrogenic Potential of MSCs (A) Schematic overview of the experimental protocol. P0, passage 0; P1, passage 1. (B and C) Proliferation rate of MSCs after 10 days of expansion (B; n = 4 donors) or up to six passages (C; n = 1 donor) (each symbol represents a passage) in the indicated media. Lines indicate the polynomial regression representatives of the number of WF-MSCs (+WNT+FGF; solid) or F-MSCs (+FGF; dotted). (D) Thionine staining (glycosaminoglycan; GAG) and collagen type II immunostaining of representative sections from cartilage pellets formed with cells expanded in the indicated conditions (n = 3 donors with three pellets per donor) after 5 weeks of chondrogenic induction. The scale bar represents 1 mm. (E) Analysis of the thionine-positive areas of pellet cultures chondrogenically differentiated in the indicated conditions (n = 3 donors with three pellets per donor). (F) Analysis of the pellet size of differentially expanded MSCs (n = 3 donors with three pellets per donor). Values represent means ± SEM of three donors. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, #p < 0.01 compared to the other conditions. Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions

Figure 2 WNT3A in Combination with FGF2 Maintains Robust Chondrogenic Potential of MSCs over Multiple Passages (A) Schematic of the experimental plan. (B) Cell-number analysis during MSC expansion. Lines indicate the polynomial regression representatives of the number of WF-MSCs (+WNT+FGF; solid) or F-MSCs (+FGF; dotted). Values represent means ± SEM (n = 3 donors, three to four pellets per donor). (C and D) MSCs were expanded for up to four passages in the indicated conditions, and pellet cultures were initiated after each passage (n = 3–5 MSC donors each passage, three pellets per donor). Shown are representative sections of the pellets after 5 weeks of chondrogenic induction, stained for glycosaminoglycans (thionine staining). Right: higher magnification of the inset areas. Numbers of cells per mm2 are indicated in the right panels (values represent the mean ± SEM of measurements performed in three different pellets from three MSC donors). The scale bars represent 1 mm (left panels) and 200 μm (right panels). Dbs, cell doublings. Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions

Figure 3 MSCs Expanded in the Presence of WNT3A and FGF2 Display Accelerated Chondrogenesis (A and B) Relative gene expression levels of COL2 and COL2B in pellet cultures from cells expanded in the indicated conditions after 3 (A) or 5 (B) weeks of chondrogenic induction. Values represent means ± SEM (n = 3 donors with three pellets per donor). ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Relative glycosaminoglycan content of pellet cultures from cells expanded in the indicated conditions. Lines indicate the polynomial regression representatives of the glycosaminoglycan accumulation in the WF-MSCs (+WNT+FGF; solid) and F-MSCs (+FGF; dotted). Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions

Figure 4 WNT Signaling Modulation In Vitro Prevents the Onset of Endochondral Ossification In Vivo (A) Collagen type X immunostaining on pellet cultures obtained from WF-MSCs (+WNT+FGF) or F-MSCs (+FGF). Representative images of three MSC donors. The scale bar represents 1 mm. (B and C) Gene expression analysis of the hypertrophic markers COL10 (B) and MMP13 (C) on pellet cultures after 3 or 5 weeks of chondrogenic induction. Pellets were obtained from MSCs (n = 3 donors and three pellets per donor) expanded in the indicated conditions. Values represent means ± SEM. ∗p < 0.05, ∗∗p < 0.01. (D) Schematic overview of the in vivo experimental protocol. (E) Pre and post in vivo analysis of pellets formed using F-MSCs (+FGF) or WF-MSCs (+WNT+FGF). GAG: thionine staining. The scale bar represents 1 mm. μCT: Quantum FX μCT 3D images of the calcified area of two representative pellets per condition. The scale bar represents 2 mm. H&E: hematoxylin and eosin staining on histological sections of decalcified samples. Black arrowheads indicate blood vessel invasion. The scale bar represents 1 mm. COL2: collagen type II immunohistochemistry on pellet cultures. The scale bars represent 150 μm (high magnification) and 400 μm (low magnification). (F) Transcript analysis of pellet cultures formed with cells expanded in the indicated conditions and chondrogenically induced without (→ST) or with IWP2 (→IWP2). Values represent means ± SEM of three pellets from three MSC donors. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. (G) Pre and post in vivo analysis of pellets formed using WF-MSCs chondrogenically differentiated with IWP2 (+WNT+FGF→IWP2). The in vivo data are representative of samples from two MSC donors, four pellets per donor and condition. Scale bars are as defined in (E). Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions

Figure 5 WNT3A and FGF2 Maintain MSC Characteristics in Multiple Passages (A) Cell morphology of MSCs expanded as indicated. The scale bar represents 200 μm. (B) Flow cytometry analysis of WF-MSCs (+WNT+FGF) and F-MSCs (+FGF). The percentage represents the number of positive cells for the indicated surface marker. Values are the mean of two MSC donors. NC, negative control. (C) Schematic representation of the working plan for the multilineage differentiation. (D) Von Kossa staining (calcium phosphate deposits) and ALP mRNA levels of MSCs expanded in the indicated conditions and subsequently differentiated in osteogenic medium. The scale bar represents 150 μm. (E) Oil red O staining (lipid accumulation) and FABP4 mRNA levels of MSCs expanded in the indicated conditions and subsequently differentiated in adipogenic medium. The scale bar represents 100 μm. Transcript analysis in (D) and (E) was performed on P4 expanded cells. Images of P1 cells are representative of two independent MSC donors; P4 images are representative of three MSC donors. ∗∗p < 0.01. (F) Gene expression profile of MSCs expanded in the indicated conditions prior to differentiation. Values represent means ± SEM. The data are representative of three MSC donors with two biological replicates per donor. ∗p < 0.05, ∗∗p < 0.01. Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions

Figure 6 WNT Signaling Modulation Regulates Cell Fate of MSCs WNT and FGF proteins maintain human MSCs in a multipotent and proliferative state. Blocking WNT signaling during chondrogenic differentiation prevents hypertrophic maturation of the cells. Stem Cell Reports 2015 4, 459-472DOI: (10.1016/j.stemcr.2015.01.017) Copyright © 2015 The Authors Terms and Conditions